This article requires a subscription to view the full text. You may purchase access to this article or login to access your subscription using the links below.
Abstract
Cis double PIK3CA mutations are common in cancers and increase sensitivity to PI3Kα inhibitors.
- ©2019 American Association for Cancer Research.
Log in using your username and password
Purchase access
You may purchase access to this article. This will require you to create an account if you don't already have one.
January 2020
Volume 10, Issue 1
Volume 10, Issue 1
PIK3CA Double Mutations in Cis May Predict PI3Kα-Inhibitor Response
Jump to section
Advertisement